Search Results for "Hypotonic Solution For Collagen Cross Linking"
Original Source: Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic Riboflavin
Corneal collagen crosslinking (CXL) has been proposed as an effective method of reducing progression of both keratoconus and corneal ectasia after surgery, as well as possibly decreasing the steepness of the cornea in these pathologies. During the CXL procedure, the central corneal thickness has been shown to significantly change. The investigator's believe that better maintenance of corneal thickness potentially could have benefits of better reproducibility of the crosslinki...
Matching Channels
CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor family and tumor marker. This receptor is expressed by activated, but not by resting, T and B cells. It...
Siemens Healthcare is the second largest medical devices company in the world (based on annual sales), with sales of $17.4 billion. Specializing in the imaging, IT, diagnostics and workflow soluti...
Matching News
Corneal Collagen Cross-Linking May Help With Keratoconus
Corneal collagen cross-linking (CXL) helps control keratoconus progression in all age groups, but it works best in adults under 40, new data suggest. Reuters Health Information
[Avedro] gets rights to [EyeGate Pharmaceuticals]' iontophoresis patents
[EyeGate Pharmaceuticals Inc.] has granted fellow ophthalmic company [Avedro Inc.] an exclusive license to its iontophoresis patents for corneal collagen cross-linking. Cross-linking is used for dege...
Keraflex® Keratoconus Treatment Study Begins in US
Avedro, Inc. and Hersh Vision Group announced today that Dr. Peter Hersh has treated the first patient in a physician sponsored Investigational New Drug (IND) study for the Safety...
SOOFT italia S.p.A., a company of OOgroup, announce the worldwide launch of its “Device and method for Corneal delivery of Riboflavin by Iontophoresis procedure for the treatmen...
NEWPORT BEACH, CA -- (Marketwire) -- 11/05/12 -- NVISION Laser Eye Centers is now enrolling patients with Keratoconus in its Collagen Cross Linking Clinical Trial. This is a physician-sponsored clini...
Avedro and EyeGate Pharma Enter Agreement for Corneal Cross-linking IP
Avedro, Inc. and EyeGate Pharma announce today that Avedro will hold the exclusive license to EyeGate Pharma’s iontophoresis patents in the field of corneal collagen cross-linki...
Avedro, EyeGate Pharma to enter agreement
EyeGate Pharma’s broad iontophoresis patent portfolio for corneal collagen cross-linking will be held as exclusive license by Avedro Inc. Delivery approach provides potential additional...
Avoid hypotonic saline use in under-16s
Hypotonic saline solution should not be used for children aged 16 years or under...
Matching PubMed Articles
CHEMICAL AND THERMAL CROSS-LINKING OF COLLAGEN AND ELASTIN HYDROLYSATES.
Chemical and thermal cross-linking of collagen soluble in acetic acid and elastin hydrolysates soluble in water have been studied. Solutions of collagen and elastin hydrolysates were treated using var...
This study quantitatively investigated the immediate effects of a photooxidative collagen cross-linking treatment with photosensitizer riboflavin (RF) and 370 nm UVA light in in vitro human corneoscle...
Collagen cross-linking for resistant corneal ulcer.
Corneal ulcer is a devastating corneal disease which is potentially sight-threatening and conventionally is treated by topical antibiotics and in some cases with more invasive procedures such as kerat...
A cross-linking reagent is required to improve mechanical strength and degradation properties of biopolymers for tissue engineering. To find the optimal preparative method, we prepared diverse genipin...
